SAM
ACAD icon

Smartleaf Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Smartleaf Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29K Sell
1,375
-1,221
-47% -$29.2K ﹤0.01% 1766
2025
Q4 		$69.3K Buy
2,596
+884
+52% +$21.1K ﹤0.01% 1392
2025
Q3 		$36.5K Buy
1,712
+885
+107% +$20.9K ﹤0.01% 1549
2025
Q2 		$18.3K Buy
827
+279
+51% +$5.19K ﹤0.01% 1593
2025
Q1 		$9.35K Sell
548
-311
-36% -$5.65K ﹤0.01% 1950
2024
Q4 		$14.3K Buy
859
+575
+202% +$9.28K ﹤0.01% 1832
2024
Q3 		$4.46K Sell
284
-141
-33% -$2.35K ﹤0.01% 2176
2024
Q2 		$6.96K Buy
+425
New +$6.86K ﹤0.01% 1619

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return